Nicorandil ameliorates mitochondrial dysfunction in doxorubicin-induced heart failure in rats: Possible mechanism of cardioprotection

Biochemical Pharmacology

Volumn 86, Issue 9, 2013, Pages 1301-1310

  Ahmed, Lamiaa A ^a   El Maraghy, Shohda A ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

Cardiotoxicity; Doxorubicin; Mitochondria; Nicorandil

Indexed keywords

ADENINE NUCLEOTIDE; CASPASE 3; CREATINE KINASE; CREATINE PHOSPHATE; CYTOCHROME C; DOXORUBICIN; NICORANDIL; PROTEIN BAX; PROTEIN BCL 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; AORTA FLOW; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA FRAGMENTATION; DRUG MECHANISM; ENZYME ACTIVITY; HEART FAILURE; HEART PROTECTION; HEART RATE; MALE; NONHUMAN; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ULTRASTRUCTURE;

CARDIOTOXICITY; DOXORUBICIN; MITOCHONDRIA; NICORANDIL;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CARCINOMA, EHRLICH TUMOR; CARDIOTONIC AGENTS; CASPASE 3; CYTOCHROMES C; DNA FRAGMENTATION; DOXORUBICIN; HEART FAILURE; HEART RATE; MALE; MICE; MITOCHONDRIA; MYOCARDIUM; NICORANDIL; OXIDATIVE PHOSPHORYLATION; RATS; RATS, WISTAR;

EID: 84886720225     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2013.07.005     Document Type: Article

References (66)

1. Y. Octavia, C.G. Tocchetti, K.L. Gabrielson, S. Janssens, H.J. Crijns, and A.L. Moens Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies J Mol Cell Cardiol 52 2012 1213 1225
2. T. Nousiainen, E. Jantunen, E. Vanninen, and J. Hartikainen Early decline in left ventricular ejection fraction predicts doxorubicin cardiotoxicity in lymphoma patients Br J Cancer 86 2002 1697 1700
3. E.D. Danz, J. Skramsted, N. Henry, J.A. Bennett, and R.S. Keller Resveratrol prevents doxorubicin cardiotoxicity through mitochondrial stabilization and the Sirt1 pathway Free Radic Biol Med 46 2009 1589 1597
4. M. Praet, and J.M. Ruysschaert In-vivo and in-vitro mitochondrial membrane damages induced in mice by adriamycin and derivatives Biochim Biophys Acta 1149 1993 79 85
5. L.C. Papadopoulou, G. Theophilidis, G.N. Thomopoulos, and A.S. Tsiftsoglou Structural and functional impairment of mitochondria in adriamycin induced cardiomyopathy in mice: suppression of cytochrome c oxidase II gene expression Biochem Pharmacol 57 1999 481 489
6. J. Milei, P. Forcada, C.G. Fraga, D.R. Grana, G. Iannelli, and M. Chiariello Relationship between oxidative stress, lipid peroxidation, and ultrastructural damage in patients with coronary artery disease undergoing cardioplegic arrest/reperfusion Cardiovasc Res 73 2007 710 719
7. M.A. Parker, V. King, and K.P. Howard Nuclear magnetic resonance study of doxorubicin binding to cardiolipin containing magnetically oriented phospholipid bilayers Biochim Biophys Acta 1514 2001 206 216
8. K.B. Wallace, and A.A. Starkov Mitochondrial targets of drug toxicity Annu Rev Pharmacol Toxicol 40 2000 353 388
9. T.K. Das, and S. Mazumdar Effect of Adriamycin on the boundary lipid structure of cytochrome c oxidase: pico-second time-resolved fluorescence depolarization studies Biophys Chem 86 2000 15 28
10. G.W. Wang, J.B. Klein, and Y.J. Kang Metallothionein inhibits doxorubicin-induced mitochondrial cytochrome c release and caspase-3 activation in cardiomyocytes J Pharmacol Exp Ther 298 2001 461 468
11. T.J. Liu, Y.C. Yeh, C.T. Ting, W.L. Lee, L.C. Wang, and H.W. Lee Ginkgo biloba extract 761 reduces doxorubicin-induced apoptotic damage in rat hearts and neonatal cardiomyocytes Cardiovasc Res 80 2008 227 235
12. K. Sakai, Y. Tsuchiya, S. Kitajima, and H. Hamada Myocardial distribution and biotransformation in vitro and in vivo of nicorandil in rats, with special reference to mitochondria J Cardiovasc Pharmacol 33 1999 163 168
13. S. Nishikawa, T. Tatsumi, J. Shiraishi, S. Matsunaga, M. Takeda, and A. Mano Nicorandil regulates Bcl-2 family proteins and protects cardiac myocytes against hypoxia-induced apoptosis J Mol Cell Cardiol 40 2006 510 519
14. M. Akao, Y. Teshima, and E. Marbán Antiapoptotic effect of nicorandil mediated by mitochondrial atp-sensitive potassium channels in cultured cardiac myocytes J Am Coll Cardiol 40 2002 803 810
15. L.A. Ahmed, H.A. Salem, A.S. Attia, and A.M. Agha Pharmacological preconditioning with nicorandil and pioglitazone attenuates myocardial ischemia/reperfusion injury in rats Eur J Pharmacol 663 2011 51 58
16. S. Abdel-aleem, M.M. El-Merzabani, M. Sayed-Ahmed, D.A. Taylor, and J.E. Lowe Acute and chronic effects of adriamycin on fatty acid oxidation in isolated cardiac myocytes J Mol Cell Cardiol 29 1997 789 797
17. O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randall Protein measurement with the Folin phenol reagent J Biol Chem 193 1951 265 275
18. P.C. Hinkle Oxygen proton and phosphate fluxes and stoichiometries G.C. Brown, C.E. Cooper, Bioenergetics: a practical approach 1995 IRL Press Oxford 1 16
19. K. Banerjee, M. Sinha, C.L.L. Pham, S. Jana, D. Chanda, and R. Cappai Synuclein induced membrane depolarization and loss of phosphorylation capacity of isolated rat brain mitochondria: Implications in Parkinson's disease FEBS Lett 584 2010 1571 1576
20. + ATPase activity and associated peroxidative damage in rat brain synaptosomes Biogerontology 9 2008 421 428
21. S.B. Rosalki An improved procedure for serum creatine phosphokinase determination Lab Clin Med 69 1967 696 705
22. E. Beutler, O. Duron, and B.M. Kelly Improved method for the determination of blood glutathione J Lab Clin Med 61 1963 882 888
23. J.A. Buege, and S.D. Aust Microsomal lipid peroxidation Methods Enzymol 52 1978 302 310
24. S.L. Marklund Pyrogallol autooxidation R.A. Greenwald, Handbook of methods for oxygen radical research 1985 CRC Press Florida 243 247
25. D.E. Paglia, and W.N. Valentine Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase J Lab Clin Med 70 1967 158 169
26. H. Abei Catalase in vitro Methods Enzymol 105 1984 121 126
27. T. Teerlink, M. Hennekes, J. Bussemaker, and J. Groeneveld Simultaneous determination of creatine compounds and adenine nucleotides in myocardial tissue by high-performance liquid chromatography Anal Biochem 214 1993 278 283
28. K.J. Livak, and T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method Methods 25 2001 402 408
29. M.W. Pfaffl A new mathematical model for relative quantification in real-time RT-PCR Nucleic Acids Res 29 2001 e45
30. R.A. Kloner, M.C. Fishbein, E. Braunwald, and P.R. Maroko Effect of propranolol on mitochondrial morphology during acute myocardial ischemia Am J Cardiol 41 1978 880 886
31. A.M. Osman, M.M. Sayed-Ahmed, M.T. Khayyal, and M.M. El-Merzabani Hyperthermic potentiation of cisplatin on solid Ehrlich carcinoma Tumori 79 1993 268 272
32. I.T. Abdel-Raheem, A. Taye, and M.M. Abouzied Cardioprotective effects of nicorandil, a mitochondrial potassium channel opener against doxorubicin-induced cardiotoxicity in rats Basic Clin Pharmacol Toxicol 2013 [Epub ahead of print]
33. M. Tokarska-Schlattner, T. Wallimann, and U. Schlattner Alterations in myocardial energy metabolism induced by the anti-cancer drug doxorubicin C R Biol 329 2006 657 668
34. K. Hoekman, W.J.F. Van der Vijgh, and J.B. Vermorken Clinical and preclinical modulation of chemotherapy-induced toxicity in patients with cancer Drugs 57 1999 133 156
35. E.H. Herman, J. Zhang, D.P. Chadwick, and V. Ferrans Comparison of the protective effects of amifostine and dexrazoxane against the toxicity of doxorubicin in spontaneously hypertensive rats Cancer Chemother Pharmacol 45 2000 329 334
36. F. Rossi, W. Filipelli, S. Russo, A. Filippelli, and L. Berrino Cardiotoxicity of doxorubicin: effects of drugs inhibiting the release of vasoactive substances Pharmacol Toxicol 75 1994 99 107
37. A.K. Dhalla, and P.K. Singal Antioxidant changes in hypertrophied and failing guinea pig hearts Am J Physiol 266 1994 1280 1285
38. T. Sato, N. Sasaki, B. O'Rourke, and E. Marbán Nicorandil, a potent cardioprotective agent, acts by opening mitochondrial ATP-dependent potassium channels J Am Coll Cardiol 35 2000 514 518
39. M. Iwasaki, Y. Hayashi, H. Yamanaka, T. Kamibayashi, and T. Mashimo Nicorandil preserves myocardial function following brain death in rats by mitochondrial adenosine triphosphate-sensitive potassium channel-dependent mechanism Eur J Cardiothorac Surg 40 2011 710 714
40. R.D. Olson, and P.S. Mushlin Doxorubicin cardiotoxicity: analysis of prevailing hypotheses FASEB J 4 1990 3076 3086
41. M. Jurczuk, J. Moniuszko-Jakoniuk, and J. Rogalska Glutathione-related enzyme activity in liver and kidney of rats exposed to cadmium and ethanol Polish J Environ Stud 15 2006 861 868
42. K.B. Wallace Doxorubicin-induced cardiac mitochondrionopathy Pharmacol Toxicol 93 2003 105 115
43. T. Li, and P.K. Singal Adriamycin-induced early changes in myocardial antioxidant enzymes and their modulation by probucol Circulation 102 2000 2105 2110
44. E.D. Wills Effect of unsaturated fatty acids and their peroxides on enzymes Biochem Pharmacol 7 1961 7 16
45. K.S. Choi, and A.L. Tappel Inactivation of ribonuclease and other enzymes by peroxidizing lipids and by malonaldehyde Biochemistry 8 1969 2827 2832
46. S. Shull, N.H. Heintz, M. Periasamy, M. Manohar, Y.M. Janssen, and J.P. Marsh Differential regulation of antioxidant enzymes in response to oxidants J Biol Chem 266 1991 24398 24403
47. D. Harman The aging process: major risk factor for disease and death Proc Nat Acad Sci U S A 88 1991 5360 5363
48. S. Mukherjee, S.K. Banerjee, M. Maulik, A.K. Dinda, K.K. Talwar, and S.K. Maulik Protection against acute adriamycin-induced cardiotoxicity by garlic: role of endogenous antioxidants and inhibition of TNF-α expression BMC Pharmacol 3 2003 16
49. B. Das, and C. Sarkar Mitochondrial KATP channel activation is important in the antiarrhythmic and cardioprotective effects of non-hypotensive doses of nicorandil and cromakalim during ischemia/reperfusion: a study in an intact anesthetized rabbit model Pharmacol Res 47 2003 447 461
50. A. Naito, Y. Aniya, and M. Sakanashi Antioxidative action of the nitrovasodilator nicorandil: inhibition of oxidative activation of liver microsomal glutathion-S-transferase and lipid peroxidation Jpn J Pharmacol 65 1994 209 213
51. S. Raveaud, J. Verdetti, and G. Faury Nicorandil protects ATP-sensitive potassium channels against oxidation-induced dysfunction in cardiomyocytes of aging rats Biogerontology 10 2009 537 547
52. J.P. Brennan, R. Southworth, R.A. Medina, S.M. Davidson, M.R. Duchen, and M.J. Shattock Mitochondrial uncoupling, with low concentration FCCP induces ROS-dependent cardioprotection independent of KATP channel activation Cardiovasc Res 72 2006 313 321
53. D. Lebrecht, B. Setzer, U.P. Ketelsen, J. Haberstroh, and U.A. Walker Time-dependent and tissue-specific accumulation of mtDNA and respiratory chain defects in chronic doxorubicin cardiomyopathy Circulation 108 2003 2423 2429
54. M. Tokarska-Schlattner, M. Zaugg, R. da Silva, E. Lucchinetti, M.C. Schaub, and T. Wallimann Acute toxicity of doxorubicin on isolated perfused heart: response of kinases regulating energy supply Am J Physiol Heart Circ Physiol 289 2005 37 47
55. A. Rudiger, and M. Singer Mechanisms of sepsis-induced cardiac dysfunction Crit Care Med 35 2007 1599 1608
56. K.D. Garlid, P. Paucek, V. Yarov-Yarovoy, H.N. Murray, R.B. Darbenzio, and A.J. D'Alonzo Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP sensitive K+ channels. Possible mechanism of cardioprotection Circ Res 81 1997 1072 1082
57. V. Sathish, V. Vimal, K.K. Ebenezar, and T. Devaki Synergistic effect of nicorandil and amlodipine on mitochondrial function during isoproterenol-induced myocardial infarction in rats J Pharm Pharmacol 54 2002 133 137
58. L. Skárka, and B. Ostádal Mitochondrial membrane potential in cardiac myocytes Physiol Res 51 2002 425 434
59. J.M. Hare Oxidative stress and apoptosis in heart failure progression Circ Res 89 2001 198 200
60. J.A. Sánchez-Alcázar, A. Khodjakov, and E. Schneider Anticancer drugs induce increased mitochondrial cytochrome c expression that precedes cell death Cancer Res 61 2001 1038 1044
61. M.R. Wolff, P.P. De Tombe, Y. Harasawa, D. Burkhoff, S. Bier, and W.C. Hunter Alterations in left ventricular mechanics, energetic and contractile reserve in experimental heart failure Circ Res 70 1992 516 529
62. D. Kumar, H. Lou, and P.K. Singal Oxidative stress and apoptosis in heart dysfunction Herz 27 2002 662 668
63. N. Sasaki, T. Sato, A. Ohler, B. O'Rourke, and E. Marbán Activation of mitochondrial ATP-dependent potassium channels by nitric oxide Circulation 101 2000 439 445
64. J.C. Goldstein, N.J. Waterhouse, P. Juin, G.I. Evan, and D.R. Green The coordinate release of cytochrome c during apoptosis is rapid, complete and kinetically invariant Nat Cell Biol 2 2000 156 162
65. M. Akao, A. Ohler, B. O'Rourke, and E. Marbán Mitochondrial ATPsensitive potassium channels inhibit apoptosis induced by oxidative stress in cardiac cells Circ Res 88 2001 1267 1275
66. Y.M. Kim, R.V. Talanian, and T.R. Billiar Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms J Biol Chem 272 1997 31138 31148